Top Stories
-
Exciting new clinical investigations, including results of the ALPINE study, show promising, more effective treatment for patients with CLL.
Topic
-
Peter encourages others to look into clinical trials and not lose hope.
Topic
-
Source:
CUIMC NewsroomDr. Jeffrey Bruce: "This new approach has the potential to transform treatment for patients with brain cancer, where the outlook for survival remains very poor."
Topic
-
Results of a multi-center study, co-led by Dr. Richard Carvajal, demonstrates a promising new immunotherapy for patients with rare uveal melanoma.
Topic
Latest News
- October 29, 2021
Sharon Howell had an encouraging response as a patient in the I-SPY clinical trials, and the outcome could also translate to a lower likelihood of her cancer coming back in the future.
Topic
- September 9, 2021
The new $10 million Columbia-Pfizer Clinical Trials Diversity Initiative will aim to reduce health disparities by increasing the participation of underrepresented minorities in clinical trials.
- July 8, 2021
New clinical trial studies the application of focused ultrasound technique to deliver chemotherapy in patients with DIPG, an aggressive type of brain cancer.
Topic
- June 5, 2021
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
- May 20, 2021
A novel drug combination is showing early promise for an entirely new, bladder-saving treatment option for patients.
- November 13, 2020
November marks Pancreatic Cancer Awareness month, and in this in-depth Q+A, Dr. Gulam Manji takes us through the exciting advances in pancreatic cancer treatment and research.
Topic
- May 4, 2020
Dr. Matthew Dallos and colleagues have opened the first clinical trial testing an anti-IL-8 compound as a potential therapy against COVID-19.
Topic
- February 24, 2020
A new clinical trial for AL amyloidosis is paving the way for a promising new treatment option for patients with the rare organ-debilitating disease.
Topic
